PVP Ventures Ltd
PVPPVP Ventures Ltd is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows.
The sharpest disagreement: the engine is strong, but at the 99th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (5 weeks in) while the P/E sits at the 99th percentile of its own 9-year range. Underneath, the last four quarters read improving, and 120% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
PVP Ventures Ltd trades at ₹64.8, in a confirmed uptrend and 5 weeks into that stage. That is +87.6% against its own 200-day average. It sits at 93% of a 52-week range of ₹24 to ₹68. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is in a confirmed uptrend — week 5 of stage 2, confirmed. At ₹64.8 it trades +87.6% versus its 200-day average and sits at 93% of its 52-week range (₹24–₹68).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +1,196% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
PVP Ventures Ltd trades at 111.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 13.4×, measured across 9.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 111.0× is about the priciest it has ever traded, against a long-run median of 13.4× measured over 9.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The price move, decomposed: over 3y, of the +83.4%/yr price move, ~−45.3%/yr came from earnings growth and ~+128.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
PVP Ventures Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +233.3% | −20.0% | +38.0% | −4.6% |
| Share price | +113.0% | +83.4% | +69.0% | +30.4% |
4-Factor Sector Score
57.9/100 — rank 4 of 26 in Realty - Construction & Contracting · 72% evidence confidence
PVP Ventures Ltd scores 57.9 out of 100 against the 26 companies it is compared with in Realty - Construction & Contracting, ranking 4. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 22.5 + 6.6 + 8.8 + 20 = 57.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
PVP Ventures Ltd reported ₹46.0 Cr of revenue in the Jun 26 quarter, +170.6% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at −4.6% a year. The last full year, FY26, came in at ₹90.0 Cr. The last four reported quarters add to ₹118 Cr.
FY26 revenue came in at ₹90.0 Cr (+233.3% on the year), capping 10 years at −4.6% compound. The latest quarter (Jun 26) printed ₹46.0 Cr, +170.6% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +338.3% growth against the decade's −4.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +187.8% over the last 4 quarters against +227.5%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
PVP Ventures Ltd's operating margin is 29.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −141.0% to 74.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 29.0%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −141.0%–74.0%.
🚨 Why the margin moved: operating margin went −0.1 pp year on year while gross margin went −13.2 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
PVP Ventures Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter. The full FY26 year was a loss of ₹10.0 Cr. That is 23.9% of the quarter's revenue. The same quarter a year earlier earned ₹0.0 Cr. 8 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹11.0 Cr, null year on year. On the full year, FY26 printed ₹−10.0 Cr (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 120% of PVP Ventures Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−23.0 Cr of operating cash against ₹−10.0 Cr of profit. After ₹292 Cr of capital spending, ₹−315 Cr was left as free cash.
FY26: operating cash of ₹−23.0 Cr against reported profit of ₹−10.0 Cr, leaving free cash of ₹−315 Cr after ₹292 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 120% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 120%: the cash cycle stretched 73 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 18.3× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
PVP Ventures Ltd's cash conversion cycle runs 106 days in FY26, up from 33 days in FY21. Capital spending ran ₹329 Cr over the last 3 years. At FY26 sales of ₹90.0 Cr each day of that cycle holds about ₹0.2 Cr, so roughly ₹26.0 Cr sits inside the business at any moment.
FY26: debtors at 106 days, inventory at 1,182 days — roughly 38.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 106 days, looser than FY21's 33.
The full loop: cash goes out to suppliers and production on day 0; stock waits 1,182 days to sell; customers pay about 106 days after that; and suppliers themselves are paid at 503 days — netting out to the 106-day cycle.
In money terms: at FY26 sales of ₹90.0 Cr, each day of the cycle holds about ₹0.2 Cr — so the 106-day loop keeps roughly ₹26.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹329 Cr over the last 3 fiscal years against ₹18.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
PVP Ventures Ltd earns a ROCE of 6% in FY26. That is up from a trough of −9% in FY19. Return on invested capital clears the cost of that capital by −11.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −11.1% net margin on 0.11× asset turns.
FY26 ROCE is 6%, recovered from a FY19 trough of −9% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): −11.1% net margin × 0.11× asset turns × 3.59× balance-sheet leverage ≈ −4.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 0.5% − 12.0% = a −11.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
PVP Ventures Ltd carries total debt of ₹256 Cr against shareholder equity of ₹406 Cr as of Mar 26, a debt-to-equity of 0.63. On the annual view that ratio went from −2.07 in FY22 to 0.63 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹256 Cr against shareholder equity of ₹406 Cr — a debt-to-equity of 0.63. On the annual view, debt-to-equity went from −2.07 (FY22) to 0.63 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of PVP Ventures Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved −0.2 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.8 points over 8 quarters to 0.1%; Domestic institutions: −0.2 points over 8 quarters to 0.0%; Promoters: −0.1 points over 8 quarters to 61.3%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
PVP Ventures Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Arihant Foundations & Housing LtdARIHANT | 65.0/100Favorable setup81% evidence | BREAKING OUT | 21.1/35 Revenue 88.8% · PAT 38.8% · OPM change 1 pp 95% evidence | 19.5/25 ROCE 17.5% · OPM 27% 95% evidence | 11.3/20 P/E 14.1× · PEG — 50% evidence | 13.1/20 RS sector 10.4% · RS bench -6.8% · 1Y -17.6%7 of 10 weeks ahead 70% evidence |
| Exact sum: 21.1 + 19.5 + 11.3 + 13.1 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Eldeco Housing & Industries LtdELDEHSG | 62.1/100Mixed-positive evidence81% evidence | ASLEEP | 27.7/35 Revenue 38.1% · PAT 100% · OPM change 25 pp 95% evidence | 14.0/25 ROCE 7.7% · OPM 36% 95% evidence | 6.9/20 P/E 21.2× · PEG — 50% evidence | 13.5/20 RS sector 28.2% · RS bench -5.6% · 1Y 2.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 27.7 + 14 + 6.9 + 13.5 = 62.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Ashiana Housing LtdASHIANA | 59.8/100Mixed-positive evidence100% evidence | ASLEEP | 29.3/35 Revenue 37% · PAT 100% · OPM change 3 pp 100% evidence | 13.5/25 ROCE 14% · OPM 7% 100% evidence | 5.6/20 P/E 29.5× · PEG 4.68 100% evidence | 11.4/20 RS sector 2.8% · RS bench 6.9% · 1Y 10.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 29.3 + 13.5 + 5.6 + 11.4 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4PVP Ventures Ltdthis pagePVP | 57.9/100Mixed-positive evidence72% evidence | BREAKING OUT | 22.5/35 Revenue 100% · PAT 100% · OPM change 0 pp 71% evidence | 6.6/25 ROCE 6.4% · OPM 29% 95% evidence | 8.8/20 P/E 111× · PEG — 15% evidence | 20.0/20 RS sector 92.4% · RS bench 99.4% · 1Y 125.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 6.6 + 8.8 + 20 = 57.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Arvind SmartSpaces LtdARVSMART | 56.6/100Mixed-positive evidence82% evidence | BREAKING OUT | 20.1/35 Revenue 5.3% · PAT 48% · OPM change 28 pp 95% evidence | 16.3/25 ROCE 12.4% · OPM 49% 76% evidence | 10.1/20 P/E 14.9× · PEG — 50% evidence | 10.1/20 RS sector -2.4% · RS bench 1.4% · 1Y -3.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 16.3 + 10.1 + 10.1 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Raymond LtdRAYMOND | 56.5/100Mixed-positive evidence75% evidence | LEADER | 18.8/35 Revenue 13.5% · PAT -80% · OPM change 3 pp 95% evidence | 9.3/25 ROCE 3.1% · OPM 13% 76% evidence | 9.0/20 P/E 39.7× · PEG — 15% evidence | 19.4/20 RS sector 91.8% · RS bench 98.2% · 1Y 63.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 9.3 + 9 + 19.4 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sunteck Realty LtdSUNTECK | 53.5/100Mixed-positive evidence93% evidence | TURNING | 26.1/35 Revenue 55.5% · PAT 31.1% · OPM change 10 pp 100% evidence | 8.3/25 ROCE 7.5% · OPM 35% 100% evidence | 13.5/20 P/E 19.8× · PEG 0.87 65% evidence | 5.6/20 RS sector -22.2% · RS bench -19.2% · 1Y -35.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 8.3 + 13.5 + 5.6 = 53.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -22.2% and the one-year return is -35.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Puravankara LtdPURVA | 53.3/100Mixed-positive evidence61% evidence | TURNING | 25.3/35 Revenue 100% · PAT 100% · OPM change 9 pp 71% evidence | 11.3/25 ROCE 11.2% · OPM 22% 76% evidence | 9.5/20 P/E 31.4× · PEG — 15% evidence | 7.2/20 RS sector -13.6% · RS bench -5.4% · 1Y -26.5%2 of 10 weeks ahead 70% evidence |
| Exact sum: 25.3 + 11.3 + 9.5 + 7.2 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9AGI Infra LtdAGIIL | 52.9/100Mixed-positive evidence93% evidence | ASLEEP | 19.2/35 Revenue 3.8% · PAT 43.1% · OPM change 9 pp 100% evidence | 19.0/25 ROCE 20.1% · OPM 42% 100% evidence | 10.7/20 P/E 33.3× · PEG 1.25 65% evidence | 4.0/20 RS sector -13.1% · RS bench -9.5% · 1Y 15.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 19 + 10.7 + 4 = 52.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Kesar India Ltd543542 | 52.3/100Mixed-positive evidence67% evidence | ASLEEP | 14.7/35 Revenue 91.9% · PAT 12.6% · OPM change -6 pp 71% evidence | 17.3/25 ROCE 23.4% · OPM 8% 76% evidence | 8.9/20 P/E 82.1× · PEG — 15% evidence | 11.4/20 RS sector 3.2% · RS bench 7.9% · 1Y 83.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 17.3 + 8.9 + 11.4 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Ajmera Realty & Infra India LtdAJMERA | 52.2/100Mixed-positive evidence82% evidence | BASING | 21.8/35 Revenue 43.3% · PAT 23.5% · OPM change -1 pp 95% evidence | 16.8/25 ROCE 14.3% · OPM 29% 76% evidence | 9.2/20 P/E 14.9× · PEG — 50% evidence | 4.4/20 RS sector -24.1% · RS bench -21.5% · 1Y -41.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 16.8 + 9.2 + 4.4 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Capacite Infraprojects LtdCAPACITE | 52.0/100Mixed-positive evidence81% evidence | ASLEEP | 15.5/35 Revenue 12.4% · PAT -5.6% · OPM change -1 pp 95% evidence | 15.3/25 ROCE 15.5% · OPM 16% 95% evidence | 14.4/20 P/E 8.8× · PEG — 50% evidence | 6.8/20 RS sector -7.6% · RS bench -20.1% · 1Y -35.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 15.5 + 15.3 + 14.4 + 6.8 = 52 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Suratwwala Business Group LtdSBGLP | 51.3/100Thin evidence · provisional56% evidence | 18.4/35 Revenue 100% · PAT 100% · OPM change 45 pp 40% evidence | 12.8/25 ROCE 12.4% · OPM 37% 71% evidence | 13.9/20 P/E 16.8× · PEG — 50% evidence | 6.2/20 RS sector -13.9% · RS bench -14.8% · 1Y -11.8%2 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 18.4 + 12.8 + 13.9 + 6.2 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Kolte Patil Developers LtdKOLTEPATIL | 49.3/100Mixed-negative evidence78% evidence | BREAKING OUT | 15.1/35 Revenue 7.8% · PAT 47.1% · OPM change 53 pp 74% evidence | 7.0/25 ROCE -0.3% · OPM 21% 100% evidence | 13.9/20 P/E 31.2× · PEG 0.74 65% evidence | 13.3/20 RS sector 1.1% · RS bench 14% · 1Y -5.9%6 of 10 weeks ahead 70% evidence |
| Exact sum: 15.1 + 7 + 13.9 + 13.3 = 49.3 · Decision use: Price leads the evidence: RS versus the benchmark is 14%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Geecee Ventures LtdGEECEE | 49.0/100Mixed-negative evidence87% evidence | BREAKING OUT | 12.1/35 Revenue -6.5% · PAT 20% · OPM change -24.9 pp 95% evidence | 9.7/25 ROCE 6.3% · OPM 28.7% 95% evidence | 9.4/20 P/E 16.7× · PEG — 50% evidence | 17.8/20 RS sector 8.9% · RS bench 13% · 1Y -5.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 9.7 + 9.4 + 17.8 = 49 · Decision use: Price leads the evidence: RS versus the benchmark is 13%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Suraj Estate Developers LtdSURAJEST | 47.9/100Mixed-negative evidence87% evidence | ASLEEP | 13.2/35 Revenue 4% · PAT 1.1% · OPM change 0 pp 95% evidence | 17.7/25 ROCE 14.5% · OPM 37% 95% evidence | 13.8/20 P/E 9.1× · PEG — 50% evidence | 3.2/20 RS sector -25.6% · RS bench -22.8% · 1Y -42%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 17.7 + 13.8 + 3.2 = 47.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 17Ganesh Housing LtdGANESHHOU | 45.5/100Mixed-negative evidence100% evidence | FADING | 4.3/35 Revenue -28.6% · PAT -54.1% · OPM change -46 pp 100% evidence | 18.2/25 ROCE 18.8% · OPM 39% 100% evidence | 12.4/20 P/E 24× · PEG 0.31 100% evidence | 10.6/20 RS sector -0.8% · RS bench 2.9% · 1Y -11.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 4.3 + 18.2 + 12.4 + 10.6 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Shriram Properties LtdSHRIRAMPPS | 44.6/100Mixed-negative evidence87% evidence | ASLEEP | 19.0/35 Revenue 37% · PAT 13.6% · OPM change -12.9 pp 95% evidence | 9.1/25 ROCE 8% · OPM -3.9% 95% evidence | 12.9/20 P/E 13.4× · PEG — 50% evidence | 3.6/20 RS sector -15.8% · RS bench -12.7% · 1Y -20.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 9.1 + 12.9 + 3.6 = 44.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Keystone Realtors LtdRUSTOMJEE | 42.3/100Mixed-negative evidence76% evidence | BASING | 17.4/35 Revenue 52.6% · PAT -26.8% · OPM change 12.7 pp 95% evidence | 10.1/25 ROCE 4.7% · OPM 17% 76% evidence | 9.0/20 P/E 37.1× · PEG — 50% evidence | 5.8/20 RS sector -11.6% · RS bench -23.4% · 1Y -44%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.4 + 10.1 + 9 + 5.8 = 42.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Omaxe LtdOMAXE | 40.7/100Mixed-negative evidence63% evidence | BREAKING OUT | 13.4/35 Revenue -8.3% · PAT 29.6% · OPM change 61.9 pp 71% evidence | 2.3/25 ROCE -110% · OPM 1.8% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.0/20 RS sector 4% · RS bench 52.4% · 1Y 42.7%6 of 10 weeks ahead 70% evidence |
| Exact sum: 13.4 + 2.3 + 10 + 15 = 40.7 · Decision use: Price leads the evidence: RS versus the benchmark is 52.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Hubtown LtdHUBTOWN | 39.3/100Mixed-negative evidence77% evidence | BASING | 13.5/35 Revenue 29.1% · PAT -12.2% · OPM change -4 pp 100% evidence | 9.4/25 ROCE 9.5% · OPM 18% 100% evidence | 9.9/20 P/E 27.4× · PEG — 15% evidence | 6.5/20 RS sector -10.6% · RS bench -20.4% · 1Y -44.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 9.4 + 9.9 + 6.5 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Valor Estate LtdDBREALTY | 37.9/100Mixed-negative evidence93% evidence | ASLEEP | 23.6/35 Revenue -49.5% · PAT 100% · OPM change 24.4 pp 100% evidence | 6.5/25 ROCE 1.6% · OPM 20.8% 100% evidence | 4.3/20 P/E 440.4× · PEG 4.19 65% evidence | 3.5/20 RS sector -20.1% · RS bench -17.3% · 1Y -43.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 6.5 + 4.3 + 3.5 = 37.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.1% and the one-year return is -43.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 23Hemisphere Properties India LtdHEMIPROP | 37.5/100Thin evidence · provisional56% evidence | BASING | 10.3/35 Revenue -4.2% · PAT -46.1% · OPM change -134.2 pp 74% evidence | 4.8/25 ROCE -1.1% · OPM — 64% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.4/20 RS sector 6.5% · RS bench -11.7% · 1Y -31.6%1 of 10 weeks ahead 70% evidence |
| Exact sum: 10.3 + 4.8 + 10 + 12.4 = 37.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Peninsula Land LtdPENINLAND | 34.0/100Adverse evidence69% evidence | TURNING | 11.5/35 Revenue -50.7% · PAT -80% · OPM change -43.7 pp 71% evidence | 6.7/25 ROCE 4.9% · OPM -19.4% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.8/20 RS sector -29% · RS bench -26.7% · 1Y -54.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11.5 + 6.7 + 10 + 5.8 = 34 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25SignatureGlobal India LtdSIGNATURE | 30.7/100Adverse evidence93% evidence | BASING | 13.0/35 Revenue -23% · PAT 100% · OPM change -11.8 pp 100% evidence | 3.5/25 ROCE 2.6% · OPM -8% 100% evidence | 7.6/20 P/E 10.1× · PEG 3.94 65% evidence | 6.6/20 RS sector -19.2% · RS bench -16.1% · 1Y -31.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13 + 3.5 + 7.6 + 6.6 = 30.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Laxmi Goldorna House LtdLGHL | 28.6/100Adverse evidence80% evidence | BASING | 8.8/35 Revenue 12.4% · PAT -80% · OPM change -6 pp 95% evidence | 10.3/25 ROCE 10.1% · OPM 12.1% 95% evidence | 8.5/20 P/E 569× · PEG — 15% evidence | 1.0/20 RS sector -31.5% · RS bench -28.8% · 1Y -46.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.8 + 10.3 + 8.5 + 1 = 28.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is PVP Ventures Ltd's share price today?
PVP Ventures Ltd trades at ₹64.8, +113.0% over the past year. The company is valued at ₹1,688 Cr. The stock sits at 93% of its 52-week range of ₹24–₹68, +87.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 5 weeks in. — as of 11 September 2026.
What were PVP Ventures Ltd's latest quarterly results?
PVP Ventures Ltd reported revenue of ₹46.0 Cr and net profit of ₹11.0 Cr for the Jun 26 quarter. Earnings per share were ₹0.46. The operating margin was 29.0%, 0.0 pp higher than a year earlier. — as of 11 September 2026.
What is PVP Ventures Ltd's revenue?
PVP Ventures Ltd reported revenue of ₹46.0 Cr in the Jun 26 quarter, +170.6% year on year. For the full FY26 fiscal year, revenue was ₹90.0 Cr (+233.3%). Over the last 10 years revenue compounded at −4.6% a year. — as of 11 September 2026.
What is PVP Ventures Ltd's profit?
PVP Ventures Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹−10.0 Cr. The operating margin ran 29.0% in the latest quarter. — as of 11 September 2026.
What is PVP Ventures Ltd's market cap?
PVP Ventures Ltd's market capitalisation is ₹1,688 Cr at a share price of ₹64.8. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is PVP Ventures Ltd's P/E ratio?
PVP Ventures Ltd trades at a P/E of 111.0×, at the 99th percentile of its own 9-year range, against a long-run median of 13.4×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does PVP Ventures Ltd pay a dividend?
No — PVP Ventures Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is PVP Ventures Ltd overvalued?
On its own history, PVP Ventures Ltd looks expensive: its P/E of 111.0× sits at the 99th percentile of its 9-year range (long-run median 13.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
How is PVP Ventures Ltd performing?
PVP Ventures Ltd is in a confirmed uptrend, 5 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
Is PVP Ventures Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 5 of stage 2), trading +87.6% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is PVP Ventures Ltd beating the market?
On recent form, yes — PVP Ventures Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +1,196% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will PVP Ventures Ltd's share price go up?
This page publishes no price forecast for PVP Ventures Ltd. What it measures instead: the share price is ₹64.8, the price is in a confirmed uptrend 5 weeks in. Its P/E of 111.0× sits at the 99th percentile of its own 9-year range. — as of 11 September 2026.
Who owns PVP Ventures Ltd?
Promoters hold 61.3% of PVP Ventures Ltd, foreign institutions 0.1%, domestic institutions 0.0% and the public 38.6% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does PVP Ventures Ltd have too much debt?
It carries real leverage — PVP Ventures Ltd's debt-to-equity is 1.18, and operating profit covers the interest bill 1×. FY26 borrowings were ₹257 Cr against equity of ₹218 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is PVP Ventures Ltd's capex?
PVP Ventures Ltd spent ₹329 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹292 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is PVP Ventures Ltd's cash flow?
PVP Ventures Ltd consumed ₹23.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−315 Cr). Reported profit that year was ₹−10.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is PVP Ventures Ltd's profit real cash?
Yes — over the last 3 fiscal years, 120% of PVP Ventures Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−23.0 Cr against reported profit of ₹−10.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is PVP Ventures Ltd in its business cycle?
PVP Ventures Ltd's FY26 operating margin was 21.0%, against a 13-year band of −141.0%–74.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 29.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the PVP Ventures Ltd story?
The sharpest disagreement: the engine is strong, but at the 99th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is PVP Ventures Ltd a stock worth studying right now?
This is not investment advice. The machine read: PVP Ventures Ltd is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!